Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Your search for
Oncology (Pediatrics) | All Regions
returned
20
studies.
Enrollment complete
Who can join
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Keywords:
Neuroblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Keywords:
Carcinoma; Neoplasms; Liver Neoplasms; Hepatoblastoma; Neoplasms; Glandular and…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)
Keywords:
Leukemia; Leukemia; Myeloid; Leukemia; Myelogenous; Chronic; BCR-ABL Positive;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
Keywords:
Oncology (Pediatrics); Oncology…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase III Randomized Trial for Patients With De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients With High Allelic Ratio FLT3/ITD
Keywords:
Oncology (Adult); Oncology (Pediatrics); AAML1031; Leukemia; Leukemia,…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase I/II, Open-Label, Single-Arm, Two-Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination With Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Keywords:
Relapsed; Refractory; B-NHL;Hematology;Oncology (Pediatrics);
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
Keywords:
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Lymphoid;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
Keywords:
Glioma; Neurofibromatoses; Neurofibromatosis 1; Neurofibroma; Neoplasms;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Keywords:
Oncology (Pediatrics); Oncology…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Keywords:
Lung Neoplasms; Carcinoma; Non-Small-Cell Lung; Respiratory Tract Neoplasms;…
Study Type:
INTERVENTIONAL |
Region:
Colorado
1
2